Evidence map›Paper›PMID 28927937›Full record

ArticleJournal of chromatography. A2017

Evaluation of intensity drift correction strategies using MetaboDrift, a normalization tool for multi-batch metabolomics data.

Chanisa Thonusin, Heidi B IglayReger, Tanu Soni, Amy E Rothberg, Charles F Burant, Charles R Evans

Abstract readEvaluation Study
In one paragraph

Article in Journal of chromatography. A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. CE-MS-Based Clinical Metabolomics of Human Plasma.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A role for decorin in improving motor deficits after traumatic brain injury.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chanisa ThonusinDepartment of Internal Medicine, University of Michigan, 6300 Brehm Tower, 1000 Wall St., Ann Arbor, MI 48109, United States; Department of Molecular and Integrative Physiology, University of Michigan, 6300 Brehm Tower, 1000 Wall St., Ann Arbor, MI 48109, United States; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Heidi B IglayRegerDepartment of Internal Medicine, University of Michigan, 6300 Brehm Tower, 1000 Wall St., Ann Arbor, MI 48109, United States.
Tanu SoniDepartment of Internal Medicine, University of Michigan, 6300 Brehm Tower, 1000 Wall St., Ann Arbor, MI 48109, United States.
Amy E RothbergDepartment of Internal Medicine, University of Michigan, 6300 Brehm Tower, 1000 Wall St., Ann Arbor, MI 48109, United States.
Charles F BurantDepartment of Internal Medicine, University of Michigan, 6300 Brehm Tower, 1000 Wall St., Ann Arbor, MI 48109, United States; Department of Molecular and Integrative Physiology, University of Michigan, 6300 Brehm Tower, 1000 Wall St., Ann Arbor, MI 48109, United States.
Charles R EvansDepartment of Internal Medicine, University of Michigan, 6300 Brehm Tower, 1000 Wall St., Ann Arbor, MI 48109, United States. Electronic address: chevans@umich.edu.

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Martin G Myers · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joyce Lee · 2010 to 2026
$20.3M
Statistics and Bioinformatics Core - WangU24DK097153 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BURANT, CHARLES F · 2012 to 2017
$10.1M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
The Metabolomics Data Center and Workbench (MDCW)U01DK097430 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUBRAMANIAM, SHANKAR · 2012 to 2017
$7.4M
Genotype-Phenotype relationships underlying aerobic capacity and metabolic healthR01DK099034 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BRITTON, STEVEN LOYAL, BURANT, CHARLES F · 2014 to 2016
$1.4M
Metabolic flux in a model of reduced oxidative capacityK25DK092558 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI EVANS, CHARLES ROBERT · 2011 to 2015
$700k
NIDDK NIH HHS K25 DK092558NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIDDK NIH HHS P30 DK092926NIDDK NIH HHS R01 DK099034NIDDK NIH HHS U01 DK097430NIDDK NIH HHS U24 DK097153
6 · The paper itself

Abstract

In recent years, mass spectrometry-based metabolomics has increasingly been applied to large-scale epidemiological studies of human subjects. However, the successful use of metabolomics in this context is subject to the challenge of detecting biologically significant effects despite substantial intensity drift that often occurs when data are acquired over a long period or in multiple batches. Numerous computational strategies and software tools have been developed to aid in correcting for intensity drift in metabolomics data, but most of these techniques are implemented using command-line driven software and custom scripts which are not accessible to all end users of metabolomics data. Further, it has not yet become routine practice to assess the quantitative accuracy of drift correction against techniques which enable true absolute quantitation such as isotope dilution mass spectrometry. We developed an Excel-based tool, MetaboDrift, to visually evaluate and correct for intensity drift in a multi-batch liquid chromatography - mass spectrometry (LC-MS) metabolomics dataset. The tool enables drift correction based on either quality control (QC) samples analyzed throughout the batches or using QC-sample independent methods. We applied MetaboDrift to an original set of clinical metabolomics data from a mixed-meal tolerance test (MMTT). The performance of the method was evaluated for multiple classes of metabolites by comparison with normalization using isotope-labeled internal standards. QC sample-based intensity drift correction significantly improved correlation with IS-normalized data, and resulted in detection of additional metabolites with significant physiological response to the MMTT. The relative merits of different QC-sample curve fitting strategies are discussed in the context of batch size and drift pattern complexity. Our drift correction tool offers a practical, simplified approach to drift correction and batch combination in large metabolomics studies.

Indexed as

SoftwareChromatography, LiquidHumansMass SpectrometryMetabolomicsMultiple Chronic ConditionsDrift correctionIntensity driftLC–MSMeal tolerance testMetabolomicsNormalization

Identifiers

PMID28927937
PMCPMC5788449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.